Victory Capital Management Inc. Has $110.65 Million Stake in Humana Inc. (NYSE:HUM)

Victory Capital Management Inc. trimmed its stake in Humana Inc. (NYSE:HUMGet Rating) by 3.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 253,055 shares of the insurance provider’s stock after selling 8,492 shares during the period. Victory Capital Management Inc. owned about 0.20% of Humana worth $110,646,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of HUM. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in Humana by 15.2% during the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 61,164 shares of the insurance provider’s stock worth $28,469,000 after acquiring an additional 8,066 shares during the period. Riverview Trust Co acquired a new stake in Humana during the 1st quarter worth about $32,000. Transcend Capital Advisors LLC grew its holdings in Humana by 18.3% during the 1st quarter. Transcend Capital Advisors LLC now owns 587 shares of the insurance provider’s stock worth $255,000 after acquiring an additional 91 shares during the period. CWM LLC acquired a new stake in Humana during the 4th quarter worth about $218,000. Finally, LPL Financial LLC grew its holdings in Humana by 5.9% during the 4th quarter. LPL Financial LLC now owns 18,367 shares of the insurance provider’s stock worth $8,520,000 after acquiring an additional 1,024 shares during the period. 94.93% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Humana stock opened at $478.35 on Thursday. Humana Inc. has a 52 week low of $351.20 and a 52 week high of $497.47. The company’s 50 day moving average price is $460.24 and its two-hundred day moving average price is $438.81. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.74. The stock has a market cap of $60.51 billion, a P/E ratio of 20.29, a P/E/G ratio of 1.42 and a beta of 0.80.

Humana (NYSE:HUMGet Rating) last posted its earnings results on Wednesday, July 27th. The insurance provider reported $8.67 EPS for the quarter, topping the consensus estimate of $7.67 by $1.00. Humana had a net margin of 3.51% and a return on equity of 17.27%. The firm had revenue of $23.66 billion for the quarter, compared to analysts’ expectations of $23.44 billion. During the same quarter last year, the firm earned $6.89 EPS. The company’s quarterly revenue was up 14.6% compared to the same quarter last year. On average, equities analysts predict that Humana Inc. will post 24.65 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on HUM shares. Credit Suisse Group set a $548.00 price target on Humana in a report on Tuesday, July 19th. StockNews.com upgraded Humana from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, April 20th. Sanford C. Bernstein initiated coverage on Humana in a research note on Thursday, May 26th. They issued a “market perform” rating and a $506.00 target price for the company. Wells Fargo & Company raised their target price on Humana from $512.00 to $514.00 and gave the company an “overweight” rating in a research note on Wednesday, May 25th. Finally, Truist Financial raised their target price on Humana from $490.00 to $550.00 and gave the company a “hold” rating in a research note on Thursday, July 14th. Five research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $499.61.

Insiders Place Their Bets

In other Humana news, insider Samir Deshpande sold 3,957 shares of Humana stock in a transaction that occurred on Tuesday, May 3rd. The shares were sold at an average price of $434.19, for a total transaction of $1,718,089.83. Following the transaction, the insider now owns 5,529 shares of the company’s stock, valued at approximately $2,400,636.51. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.39% of the company’s stock.

Humana Profile

(Get Rating)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMGet Rating).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.